Showing results (91-100 of 25,842) with videos related to

Sort By:
Pageof 2,585
Anticancer Research|January 29, 2011
Oncogramme, a new promising method for individualized breast tumour response testing for cancer treatmentS Giraud, E Loum, B Bessette, et al.
Anticancer Research|January 29, 2011
Hepatic arterial infusion in the treatment of liver metastases with PEG liposomes in combination with degradable starch microspheres (DSM) increases tumor 5-FU concentration. an animal study in CC-531 liver tumor-bearing ratsU Pohlen, R Reszka, H J Buhr, et al.
Anticancer Research|January 29, 2011
Anticancer and antimetastatic activities of Renieramycin M, a marine tetrahydroisoquinoline alkaloid, in human non-small cell lung cancer cellsHasseri Halim, Preedakorn Chunhacha, Khanit Suwanborirux, et al.
Anticancer Research|January 29, 2011
A phase II study of weekly paclitaxel and doxifluridine combination chemotherapy for advanced/recurrent gastric cancerIzumi Takeyoshi, Fujio Makita, Yoshifumi Tanahashi, et al.
Anticancer Research|January 29, 2011
Successful S-1 monotherapy for chemorefractory thymic carcinomaTomonobu Koizumi, Toshihiko Agatsuma, Yoshimichi Komatsu, et al.
Anticancer Research|January 29, 2011
Prognostic value of the human antigen R (HuR) in human breast cancer: high level predicts a favourable prognosisZhu Yuan, Andrew J Sanders, Lin Ye, et al.
Anticancer Research|October 15, 2010
Transient metals enhance cytotoxicity of curcumin: potential involvement of the NF-kappaB and mTOR signaling pathwaysJessica R Lou, Xiao-Xi Zhang, Jie Zheng, et al.
Anticancer Research|October 15, 2010
Topoisomerase I deficiency results in chromosomal alterations in cervical cancer cellsEigil Kjeldsen, David Tordrup, Gerda M Hübner, et al.
Anticancer Research|October 15, 2010
Expression of dysadherin and cytokeratin as prognostic indicators of disease-free survival in patients with stage I NSCLCKenji Ono, Hidetaka Uramoto, Takeshi Hanagiri
Anticancer Research|October 15, 2010
Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinomaStéphanie Cludts, Christine Decaestecker, Bryon Johnson, et al.
Pageof 2,585